Announced Thu, 16 Oct · 15:17 IST

Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve Unaudited Standalone ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hindustan Bio Sciences Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 31 October 2025 at 2:00 p.m. at the registered office in Hyderabad. The primary agenda is to consider and approve the unaudited standalone financial results of the company for the quarter and half year ended 30 September 2025. The meeting also includes a general agenda item for any other matter with the Chair's permission. The intimation is filed under Regulation 29(1)(a) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

This is a routine regulatory filing and does not itself contain financial data. Investors should watch for the actual Q2/H1 FY26 results, which are likely to be released shortly after the board meeting and may influence short-term stock sentiment.